| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192172 | Annals of Allergy, Asthma & Immunology | 2011 | 7 Pages |
Abstract
In this study, flunisolide HFA did not suppress growth or bone maturation at the highest approved dose for children with persistent asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
George W. MD, Leon S. MD, Sandra DO, Euloge PhD, Kenneth B. MD,